A new jab, that could end the agony of back pain, has got an approval from European regulators.
During experiments, the Cimzia jabs showed rapid improvements in pain, stiffness and mobility, the Daily Express reported.
The breakthrough fortnightly injection can allow back pain sufferers to enjoy activities and run errands they couldn’t do before.
Sufferers can experience increased pain when resting which improves with exercise, painful inflammation of tendons and ligaments, arthritis, sore red eyes known as uveitis, and inflammatory bowel disease.
Dr Stefan Siebert, a senior lecturer in rheumatology at the University of Glasgow, said with advances in imaging technology, better diagnostic criteria and new treatments they now have the opportunity to improve patients’ symptoms and avert long-term disability.
Cimzia is administered every fortnight but after two jab s it can be administered monthly.